Ronald Sluyter
Department of Medicine
Nepean Clinical School
University of Sydney
Penrith
Australia
Name/email consistency: high
- P2X(7) receptor activation causes phosphatidylserine exposure in human erythrocytes. Sluyter, R., Shemon, A.N., Wiley, J.S. Biochem. Biophys. Res. Commun. (2007)
- Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes. Sluyter, R., Shemon, A.N., Hughes, W.E., Stevenson, R.O., Georgiou, J.G., Eslick, G.D., Taylor, R.M., Wiley, J.S. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2007)
- Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. Sluyter, R., Shemon, A.N., Wiley, J.S. J. Immunol. (2004)
- P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Sluyter, R., Dalitz, J.G., Wiley, J.S. Genes Immun. (2004)
- Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors. Sluyter, R., Wiley, J.S. Int. Immunol. (2002)
- Detection of P2X purinergic receptors on human B lymphocytes. Sluyter, R., Barden, J.A., Wiley, J.S. Cell Tissue Res. (2001)